Supporting your AOD-9604 protocol The peptide does not work in isolation
Clinical research has confirmed no effect on IGF-1 levels and no negative impact on carbohydrate metabolism
It is not approved by the FDA for clinical use, diagnostics, or therapeutic procedures in humans or animals
Dosing Calculation Examples If you reconstituted a 5 mg vial with 2 mL bacteriostatic water , your concentration is 2,500 mcg/mL: For 250 mcg dose: Draw 0.10 mL (10 units on insulin syringe) For 300 mcg dose: Draw 0.12 mL (12 units on insulin syringe) For 500 mcg dose: Draw 0.20 mL (20 units on insulin syringe) AOD-9604 Administration Guide Proper subcutaneous injection technique ensures optimal absorption, minimizes discomfort, and reduces risk of injection site reactions
A clean approach to stubborn adipose tissue
Individuals taking medications for diabetes, thyroid disorders, or other metabolic conditions should use AOD-9604 only under medical supervision with appropriate monitoring